Oliver C Turner (Oliver Turner)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 16

Top Venues

Toxicologic pathology

Science translational medicine

ILAR journal

Novartis

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Novartis Jun 02 2003

United States

Pathologist :: Preclinical Safety

Publications

Anette C Karle, Matthias B Wrobel, Stephan Koepke, Michael Gutknecht, Sascha Gottlieb, Brigitte Christen, Tina Rubic-Schneider, Ingrid Pruimboom-Brees, Xavier Charles Leber, Meike Scharenberg, Benjamin Maciejewski, Oliver C Turner, Chandrassegar Saravanan, François Huet, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Jeffrey D Kearns, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events. Science translational medicine 15 (681) (2023)
Anette C Karle, Matthias B Wrobel, Stephan Koepke, Michael Gutknecht, Sascha Gottlieb, Brigitte Christen, Tina Rubic-Schneider, Ingrid Pruimboom-Brees, Xavier Charles Leber, Meike Scharenberg, Benjamin Maciejewski, Oliver C Turner, Chandrassegar Saravanan, François Huet, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Jeffrey D Kearns, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events. Science translational medicine 15 (681) (2023)
Anette C Karle, Matthias B Wrobel, Stephan Koepke, Michael Gutknecht, Sascha Gottlieb, Brigitte Christen, Tina Rubic-Schneider, Ingrid Pruimboom-Brees, Xavier Charles Leber, Meike Scharenberg, Benjamin Maciejewski, Oliver C Turner, Chandrassegar Saravanan, François Huet, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Jeffrey D Kearns, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events. Science translational medicine 15 (681) (2023)
Xavier Palazzi, Erio Barale, Bhupinder Bawa, Jonathan Carter, Kyathanahalli S Janardhan, Heike Antje Marxfeld, Abraham Nyska, Chandrassegar Saravanan, Dirk Schaudien, Vanessa L Schumacher, Robert H Spaet, Simone Tangermann, Oliver C Turner, Enrico Vezzali
Results of the European Society of Toxicologic Pathology Survey on the Use of Artificial Intelligence in Toxicologic Pathology. Toxicologic pathology 51 (4) (2023)
Anette C Karle, Matthias B Wrobel, Stephan Koepke, Michael Gutknecht, Sascha Gottlieb, Brigitte Christen, Tina Rubic-Schneider, Ingrid Pruimboom-Brees, Xavier Charles Leber, Meike Scharenberg, Benjamin Maciejewski, Oliver C Turner, Chandrassegar Saravanan, François Huet, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Jeffrey D Kearns, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events. Science translational medicine 15 (681) (2023)
Thomas Forest, Famke Aeffner, Dinesh S Bangari, Bhupinder Bawa, Jonathan Carter, James D Fikes, Wanda B High, Shim-Mo Hayashi, Matthew Jacobsen, LuAnn McKinney, Daniel G Rudmann, Thomas J Steinbach, Vanessa L Schumacher, Oliver C Turner, Jerrold M Ward, Cynthia J Willson
Scientific and Regulatory Policy Committee Points to Consider: Primary Digital Histopathology Evaluation and Peer Review for Good Laboratory Practice (GLP) Nonclinical Toxicology Studies. Toxicologic pathology 50 (4) (2022)
Thomas Forest, Famke Aeffner, Dinesh S Bangari, Bhupinder Bawa, Jonathan Carter, James D Fikes, Wanda B High, Shim-Mo Hayashi, Matthew Jacobsen, LuAnn McKinney, Daniel G Rudmann, Thomas J Steinbach, Vanessa L Schumacher, Oliver C Turner, Jerrold M Ward, Cynthia J Willson
Scientific and Regulatory Policy Committee Brief Communication: 2019 Survey on Use of Digital Histopathology Systems in Nonclinical Toxicology Studies. Toxicologic pathology 50 (3) (2022)
Chandra Saravanan, Thierry D Flandre, Carolyn L Hodo, Anne D Lewis, Lars Mecklenburg, Annette Romeike, Oliver C Turner, Hsi-Yu Yen
Research Relevant Conditions and Pathology in Nonhuman Primates. ILAR journal (2021)
Oliver C Turner, Brian Knight, Aleksandra Zuraw, Geert Litjens, Daniel G Rudmann
Mini Review: The Last Mile-Opportunities and Challenges for Machine Learning in Digital Toxicologic Pathology. Toxicologic pathology 49 (4) (2021)
Holger Hoefling, Tobias Sing, Imtiaz Hossain, Julie Boisclair, Arno Doelemeyer, Thierry D Flandre, Alessandro Piaia, Vincent Romanet, Gianluca Santarossa, Chandrassegar Saravanan, Esther Sutter, Oliver C Turner, Kuno Wuersch, Pierre Moulin
HistoNet: A Deep Learning-Based Model of Normal Histology. Toxicologic pathology 49 (4) (2021)
Vladimir Bantseev, Typhaine Lejeune, Steven D Sorden, Margarita M Gruebbel, Kenneth A Schafer, Brian Short, Cindy Farman, Meg Ferrell Ramos, Bindu M Bennet, Krishna Yekkala, Elke-Astrid Atzpodien, Oliver C Turner, Jaqueline Brassard, George Foley
Scientific and Regulatory Policy Committee Points to Consider: Fixation, Trimming, and Sectioning of Nonrodent Eyes and Ocular Tissues for Examination in Ocular and General Toxicity Studies. Toxicologic pathology (2021)
Anantharaman Muthuswamy, Henry Chen, Ying Hu, Oliver C Turner, Olulanu H Aina
Mammalian Retinal Cell Quantification. Toxicologic pathology 49 (3) (2020)
François Huet, Jackie Miller, Paul E Miller, Christopher M Hayden, James J Glick, Adam Bentley, Chris De Benedetto, Leslie E McPherson, Oliver C Turner
Observation of Silicone Oil Within the Vitreous and Sclera Following Intravitreal Administration of Biotherapeutics Using Insulin Syringes in Cynomolgus Monkeys. Toxicologic pathology 49 (3) (2020)
Steven D Sorden, Thomas Larsen, Leslie E McPherson, Oliver C Turner, Erica E Carroll, Alok K Sharma
Spontaneous Background and Procedure-Related Microscopic Findings and Common Artifacts in Ocular Tissues of Laboratory Animals in Ocular Studies. Toxicologic pathology 49 (3) (2020)
Kyathanahalli S Janardhan, Rebecca Kohnken, Oliver C Turner, Channabasavaiah B Gurumurthy, Ramesh C Kovi
Looking Forward: Cutting-Edge Technologies and Skills for Pathologists in the Future. Toxicologic pathology 47 (8) (2019)
Oliver C Turner, Famke Aeffner, Dinesh S Bangari, Wanda High, Brian Knight, Tom Forest, Brieuc Cossic, Lauren E Himmel, Daniel G Rudmann, Bhupinder Bawa, Anantharaman Muthuswamy, Olulanu H Aina, Elijah F Edmondson, Chandrassegar Saravanan, Danielle L Brown, Tobias Sing, Manu M Sebastian
Society of Toxicologic Pathology Digital Pathology and Image Analysis Special Interest Group Article*: Opinion on the Application of Artificial Intelligence and Machine Learning to Digital Toxicologic Pathology. Toxicologic pathology 48 (2) (2019)

Oliver C Turner.css-eqlu8i{font-size:small;padding-left:4px;} (Oliver Turner)

Publication Activity (10 Years)

Top Topics

Top Venues

Oliver C Turner (Oliver Turner)